Global & Southeast Asia Protein Purification & Isolation Market Trends

Growth Drivers

Growing Need for More Accurate Purification Kit- Protein purification and isolation methods are being pushed even further by ongoing technical breakthroughs. Traditional technologies such as agarose beads and other resins are being replaced by magnetic and protein fragments, as well as ligand tagging systems. Furthermore, the growing usage of automated analyzers is likely to increase requirements for protein purification and separation. Thermo Fisher Scientific Inc. (US) introduced the KingFisher Apex Purification System in April 2021, a protein-rich sample purification equipment enabling researchers to separate DNA, proteins, and cells. This technology aids in protein and cell isolation while also providing a highly tailored procedure for the adaptive, reproducible, and rapid creation of samples at no additional expense. It uses automated technologies to provide error-free reports as well as high-quality nucleic acids and proteins. In 25 to 65 minutes, this protein purification system can operate 24 to 96 samples.

Increasing Research & Developmental Activities- Governing bodies are increasingly investing in R&D and undertaking initiatives that promote the development and growth of pharmaceutical and biotechnology markets. For protein purification and isolation solutions, pharmaceutical is a highly lucrative industry owing to the significant investments in the development of biomarker-specific molecules. In the preclinical drug development phase, the precise isolation of proteins with a significant amount of purified substrate is a vital component. On the other hand, technological advancements in the protein purification and isolation process, such as the increasing preference for magnetic and protein beads and ligand tagging systems over traditional methods, such as agarose beads and other resins, coupled with the rising utilization of automated analyzers are anticipated to drive the growth of the global and Southeast Asia protein purification & isolation market. According to a report issued by Research America in January 2022, the projected Pharmaceutical and Health R&D Expenditure in the United States in 2020 was USD 245,127 million, while it was roughly USD 221,438 million in 2019. 

Application in the study and assessment of the severe acute respiratory syndrome coronavirus (SARS-CoV-2)- based on a study titled "Recombinant Protein Expression and Purification of N, S1, and RBD of SARS-CoV-2 from Mammalian Cells and Their Potential Applications" published by the National Library of Medicine in September 2021, there is an enormous need for screening and serological resources worldwide, as countries must develop their own methods for the manufacture of superior biomolecules.

Increased investment in the pharmaceutical business- India's pharmaceutical sector is predicted to be worth $65 billion by 2024 and $130 billion by 2030. India is an influential pharmaceutical exporter, with over 200 nations covered by Indian pharmaceutical shipments.

Challenges

High Cost of Instruments and Tools

The high costs of instruments and tools hamper the adoption rate of protein purification and isolation solutions dramatically. Additionally, the difficulties observed in maintaining one size that fits all purification kits of sample preparation in the laboratory, coupled with the factors such as the high costs and problems with scaling up the purification and isolation processes and the doubts about the efficiency of the solutions are some of the factors anticipated to limit the growth of the global and Southeast Asia protein purification & isolation market.

A Scarcity of Qualified Personnel

A reduction in the rate of deployment of new equipment